Compare · SGE vs TMO
SGE vs TMO
Side-by-side comparison of Strong Global Entertainment Inc. (SGE) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- SGE operates in Consumer Discretionary, while TMO operates in Industrials - the two are in different parts of the market.
- TMO carries a market cap of $176.13B.
- TMO has hit the wire 19 times in the past 4 weeks while SGE has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for SGE).
- Company
- Strong Global Entertainment Inc.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- -
- $176.13B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 2023
- News (4w)
- 0
- 19
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest SGE
- SEC Form EFFECT filed by Strong Global Entertainment Inc.
- SEC Form EFFECT filed by Strong Global Entertainment Inc.
- SEC Form 15-12G filed by Strong Global Entertainment Inc.
- SEC Form POS AM filed by Strong Global Entertainment Inc.
- SEC Form POS AM filed by Strong Global Entertainment Inc.
- CFO, Secretary & Treasurer Major Todd Robert disposed of 16,374 shares, closing all direct ownership in the company (SEC Form 4)
- Director Govignon Richard Edward Jr disposed of 26,250 units of Class A Common Voting Stock, closing all direct ownership in the company (SEC Form 4)
- Director King Marsha G disposed of 26,250 units of Class A Common Voting Shares, closing all direct ownership in the company (SEC Form 4)
- Director Struble John W. disposed of 26,250 units of Class A Common Voting Shares, closing all direct ownership in the company (SEC Form 4)
- Director Cerminara Kyle disposed of 36,250 units of Class A Common Voting Shares, closing all direct ownership in the company (SEC Form 4)
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)